Glycorex’s unique molecular level technology that specifically selects and removes antibodies in
the blood has opened up revolutionary treatments and solutions in healthcare.
Optimizing blood for life – solutions for improved
quality of life and better health economy
Glycosorb® ABO enables higher quality of life, saves lives in emergency surgeries and has positive health ecomoics effects.
Glycosorb® ABO is a medical device that enables organ transplants across the blood group barrier. Since the first transplant in 2001, the treatment method has shown to be effective, gentle and safe for the patient and is used for both adults and children.
Glycosorb® ABO 4ml reduces the presence of anti-A/B antibodies in human plasma and can thus enable production of universal blood components
The company’s product variant of Glycosorb® ABO for universal blood components is a unique medical device, designed for the specific reduction of anti-A/B antibodies in blood plasma without significantly affecting other antibodies or vital blood components.
- Specific reduction of anti-A/B antibodies in blood plasma
- Enables production of universal blood components
- Facilitates transfusions to patients regardless of blood group
Glycorex Product Benefits
Glycorex – Optimizing Blood for Life
Glycorex’s molecular-level technology selectively removes antibodies from blood, enabling transplants across blood groups, increasing transplant availability, and providing health economic benefits.